Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

T. C. Lynn, R. P. Hsieh, K. T. Lin, M. C. Shen, D. S. Chen, C. H. Wang, C. H. Liu, J. H. Wang, M. Y. Lai, M. F. Liou, M. R. Hsieh, C. Y. Chuang, R. Ting, Jacqueline Whang-Peng

Research output: Contribution to journalArticle

Abstract

A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

Original languageEnglish
Pages (from-to)172-176
Number of pages5
JournalZhonghua minguo weishengwu ji mianyixue zazhi
Volume17
Issue number3
Publication statusPublished - Aug 1 1984
Externally publishedYes

Fingerprint

Deltaretrovirus Antibodies
Anti-Idiotypic Antibodies
Enzyme-Linked Immunosorbent Assay
Neoplasms
Reading
Hepatocellular Carcinoma
Antibodies
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lynn, T. C., Hsieh, R. P., Lin, K. T., Shen, M. C., Chen, D. S., Wang, C. H., ... Whang-Peng, J. (1984). Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report. Zhonghua minguo weishengwu ji mianyixue zazhi, 17(3), 172-176.

Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics : a preliminary report. / Lynn, T. C.; Hsieh, R. P.; Lin, K. T.; Shen, M. C.; Chen, D. S.; Wang, C. H.; Liu, C. H.; Wang, J. H.; Lai, M. Y.; Liou, M. F.; Hsieh, M. R.; Chuang, C. Y.; Ting, R.; Whang-Peng, Jacqueline.

In: Zhonghua minguo weishengwu ji mianyixue zazhi, Vol. 17, No. 3, 01.08.1984, p. 172-176.

Research output: Contribution to journalArticle

Lynn, TC, Hsieh, RP, Lin, KT, Shen, MC, Chen, DS, Wang, CH, Liu, CH, Wang, JH, Lai, MY, Liou, MF, Hsieh, MR, Chuang, CY, Ting, R & Whang-Peng, J 1984, 'Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.', Zhonghua minguo weishengwu ji mianyixue zazhi, vol. 17, no. 3, pp. 172-176.
Lynn, T. C. ; Hsieh, R. P. ; Lin, K. T. ; Shen, M. C. ; Chen, D. S. ; Wang, C. H. ; Liu, C. H. ; Wang, J. H. ; Lai, M. Y. ; Liou, M. F. ; Hsieh, M. R. ; Chuang, C. Y. ; Ting, R. ; Whang-Peng, Jacqueline. / Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics : a preliminary report. In: Zhonghua minguo weishengwu ji mianyixue zazhi. 1984 ; Vol. 17, No. 3. pp. 172-176.
@article{d4509a3fec7d47ea83474e3000c229ce,
title = "Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.",
abstract = "A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.",
author = "Lynn, {T. C.} and Hsieh, {R. P.} and Lin, {K. T.} and Shen, {M. C.} and Chen, {D. S.} and Wang, {C. H.} and Liu, {C. H.} and Wang, {J. H.} and Lai, {M. Y.} and Liou, {M. F.} and Hsieh, {M. R.} and Chuang, {C. Y.} and R. Ting and Jacqueline Whang-Peng",
year = "1984",
month = "8",
day = "1",
language = "English",
volume = "17",
pages = "172--176",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "0253-2662",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

TY - JOUR

T1 - Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics

T2 - a preliminary report.

AU - Lynn, T. C.

AU - Hsieh, R. P.

AU - Lin, K. T.

AU - Shen, M. C.

AU - Chen, D. S.

AU - Wang, C. H.

AU - Liu, C. H.

AU - Wang, J. H.

AU - Lai, M. Y.

AU - Liou, M. F.

AU - Hsieh, M. R.

AU - Chuang, C. Y.

AU - Ting, R.

AU - Whang-Peng, Jacqueline

PY - 1984/8/1

Y1 - 1984/8/1

N2 - A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

AB - A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

UR - http://www.scopus.com/inward/record.url?scp=0021476276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021476276&partnerID=8YFLogxK

M3 - Article

C2 - 6096089

AN - SCOPUS:0021476276

VL - 17

SP - 172

EP - 176

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 0253-2662

IS - 3

ER -